Jan Astermark

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 32

Top Topics

Physical Activity

Psychometric Properties

Acute Coronary Syndrome

Top Venues

Haemophilia : the official journal of the World Federation of Hemophilia

Thrombosis and haemostasis

This page only lists publications with an associated author ORCID identifier.

Publications

Alexandros Arvanitakis, Caroline Jepsen, Nadine G Andersson, Fariba Baghaei, Jan Astermark
Primary prophylaxis implementation and long-term joint outcomes in Swedish haemophilia A patients. Haemophilia : the official journal of the World Federation of Hemophilia 30 (3) (2024)
Alexandros Arvanitakis, Caroline Jepsen, Nadine G Andersson, Fariba Baghaei, Jan Astermark
Primary prophylaxis implementation and long-term joint outcomes in Swedish haemophilia A patients. Haemophilia : the official journal of the World Federation of Hemophilia (2024)
Nadine G Andersson, Hannes Brange, Jan Astermark, Malin Axelsson, Fariba Baghaei, Maria Magnusson, Anna Olsson, Elsa Olsson, Susanna Ranta, Linda Myrin Westesson, Margareta Holmström
Low bleeding rates after intramuscular Covid-19 vaccination in patients with haemophilia and von Willebrand disease: Outcome data from the Swedish haemophilia registry. Haemophilia : the official journal of the World Federation of Hemophilia (2024)
Cedric Hermans, Jan Astermark, Manuela Carvalho, Gerry Dolan, Roseline d'Oiron, Andreas Greinacher, Pål André Holme, Tami Livnat, Robert Klamroth, Maria Elisa Mancuso, Natascha Marquardt, Ramiro Nunez, Olga Katsarou, Ingrid Pabinger-Fasching, Gabriele Quintavalle, Ryan Rodgers, Paul van der Valk, Jerzy Windyga, Victor Jimenez Yuste, Irena Preložnik Zupan
Prevalence of COVID-19 related hospitalizations and mortality in adults aged ≥40 years with haemophilia: A survey from Europe. Haemophilia : the official journal of the World Federation of Hemophilia (2023)
Kristina Kihlberg, Fariba Baghaei, Maria Bruzelius, Eva Funding, Pål Andre Holme, Riitta Lassila, Vuokko Nummi, Susanna Ranta, Nadine G Andersson, Erik Berntorp, Jan Astermark
No difference in quality of life between persons with severe haemophilia A and B. Haemophilia : the official journal of the World Federation of Hemophilia (2023)
Jan Astermark, Tyler W Buckner, Laurent Frenzel, Anthony J Hatswell, Xiaojun You, Hai Liu, Erin Goodman, Sandra Santos, Charles Hawes, David Hinds, Robert Klamroth
Matching-adjusted indirect comparison of bleeding outcomes in severe haemophilia A: Comparing valoctocogene roxaparvovec gene therapy, emicizumab prophylaxis, and FVIII replacement prophylaxis. Haemophilia : the official journal of the World Federation of Hemophilia (2023)
Alexandros Arvanitakis, Pål Andre Holme, Erik Berntorp, Jan Astermark
Impact of timing of prophylaxis commencement, F8 genotype and age on factor consumption and health-related quality of life in patients with severe haemophilia A. Haemophilia : the official journal of the World Federation of Hemophilia (2023)
Ragnhild J Måseide, Erik Berntorp, Jan Astermark, Anna Olsson, Maria Bruzelius, Tony Frisk, Vuokko Nummi, Riitta Lassila, Geir E Tjønnfjord, Pål A Holme
Health-related quality of life and physical activity in Nordic patients with moderate haemophilia A and B (the MoHem study). Haemophilia : the official journal of the World Federation of Hemophilia (2023)
Cedric Hermans, Jan Astermark, Manuela Carvalho, Gerry Dolan, Roseline d'Oiron, Andreas Greinacher, Pål André Holme, Tami Livnat, Robert Klamroth, Maria Elisa Mancuso, Natascha Marquardt, Ramiro Nunez, Olga Katsarou, Ingrid Pabinger-Fasching, Gabriele Quintavalle, Ryan Rodgers, Paul van der Valk, Jerzy Windyga, Victor Jimenez Yuste, Irena Preložnik Zupan
Prevalence of COVID-19 related hospitalizations and mortality in adults aged ≥40 years with haemophilia: A survey from Europe. Haemophilia : the official journal of the World Federation of Hemophilia (2023)
Alexandros Arvanitakis, Pål Andre Holme, Erik Berntorp, Jan Astermark
Clinical outcome and adherence rate in Scandinavian patients with intermediate-intensity prophylaxis before and after the switch of standard half-life FVIII products to BAY 81-8973. Haemophilia : the official journal of the World Federation of Hemophilia 28 (2) (2022)
Hanjing Xie, Rolf C R Ljung, Jan Astermark, Terese Hylander
Autologous cell therapy - A new concept to eradicate inhibitors in haemophilia. Haemophilia : the official journal of the World Federation of Hemophilia 28 (6) (2022)
Erik Berntorp, Petra LeBeau, Margaret V Ragni, Munira Borhany, Yasmina L Abajas, Michael D Tarantino, Katharina Holstein, Stacy E Croteau, Riana Liesner, Cristina Tarango, Manuela Carvalho, Catherine E McGuinn, Eva Funding, Christine L Kempton, Christoph Bidlingmaier, Alice Cohen, Johannes Oldenburg, Susan Kearney, Christine Knoll, Philip Kuriakose, Suchitra Acharya, Ulrike M Reiss, Roshni Daniel Kulkarni, Michelle Witkop, Stefan Lethagen, Rebecca Krouse, Amy D Shapiro, Jan Astermark
Quality of life in a large multinational haemophilia B cohort (The B-Natural study) - Unmet needs remain. Haemophilia : the official journal of the World Federation of Hemophilia 28 (3) (2022)
Amy D Shapiro, Pantep Angchaisuksiri, Jan Astermark, Gary Benson, Giancarlo Castaman, Hermann Eichler, Victor Jimenez Yuste, Kaan Kavakli, Tadashi Matsushita, Lone Hvitfeldt Poulsen, Allison P Wheeler, Guy Aaron Young, Silva Zupančić-Šalek, Johannes Oldenburg, Pratima Chowdary
Long-term efficacy and safety of subcutaneous concizumab prophylaxis in hemophilia A and hemophilia A/B with inhibitors. Blood advances 6 (11) (2022)
Robert Klamroth, Cihan Ay, Philippe De Moerloose, Andreas Greinacher, Jerzy Windyga, Jan Astermark, Erik Berntorp, Manuela Carvalho, Gerard Dolan, Cedric Hermans, Pål Andre Holme, Tami Livnat, Maria Elisa Mancuso, Natascha Marquardt, Ramiro Nunez, Ingrid Pabinger-Fasching, Ryan Rodgers, Paul van der Valk, Victor Jimenez Yuste, Irena Preložnik Zupan
Applicability of the European Society of Cardiology Guidelines on the management of acute coronary syndromes to older people with haemophilia A - A modified Delphi consensus by the ADVANCE Working Group. Haemophilia : the official journal of the World Federation of Hemophilia (2022)
Anna-Elina Lehtinen, Fariba Baghaei, Jan Astermark, Pål André Holme
Surgical outcomes in patients with haemophilia A or B receiving extended half-life recombinant factor VIII and IX Fc fusion proteins: Real-world experience in the Nordic countries. Haemophilia : the official journal of the World Federation of Hemophilia 28 (5) (2022)
Anna Olsson, Linda Myrin Westesson, Fariba Baghaei, Margareta Holmström, Elsa Olsson, Maria Magnusson, Susanna Ranta, Jan Astermark, Nadine G Andersson, Judith Thanner, Johan Szamosi, Loudin Daoura, Karin Sennfält
Real-world prophylactic usage of recombinant factor IX Fc in Sweden: A report from the Swedish National Registry for bleeding disorders. Haemophilia : the official journal of the World Federation of Hemophilia (2022)
Jan Astermark, Katharina Holstein, Yasmina L Abajas, Susan Kearney, Stacy E Croteau, Riana Liesner, Eva Funding, Christine L Kempton, Suchitra Acharya, Stefan Lethagen, Petra LeBeau, Joel Bowen, Erik Berntorp, Amy D Shapiro
The B-Natural study-The outcome of immune tolerance induction therapy in patients with severe haemophilia B. Haemophilia : the official journal of the World Federation of Hemophilia 27 (5) (2021)
Ragnhild J Måseide, Erik Berntorp, Jan Astermark, Jessica Hansen, Anna Olsson, Maria Bruzelius, Tony Frisk, Magnus Aspdahl, Vuokko Nummi, Geir E Tjønnfjord, Pål A Holme
Haemophilia early arthropathy detection with ultrasound and haemophilia joint health score in the moderate haemophilia (MoHem) study. Haemophilia : the official journal of the World Federation of Hemophilia 27 (2) (2021)
Jan Astermark, Cihan Ay, Manuela Carvalho, Roseline D'Oiron, Philippe De Moerloose, Gerard Dolan, Andreas Greinacher, Cedric Hermans, Pål Andre Holme, Olga Katsarou, Gili Kenet, Robert Klamroth, Maria Elisa Mancuso, Natascha Marquardt, Ramiro Núñez, Ingrid Pabinger, Robert Tait, Paul van der Valk
New Inhibitors in the Ageing Population: A Retrospective, Observational, Cohort Study of New Inhibitors in Older People with Hemophilia. Thrombosis and haemostasis (2021)
Gerard Dolan, Jan Astermark, Cedric Hermans
Recombinant FVIIa in elective non-orthopaedic surgery of adults with haemophilia and inhibitors: A systematic literature review. Haemophilia : the official journal of the World Federation of Hemophilia 27 (3) (2021)
Margareta Holmström, Elsa Olsson, Jan Astermark, Malin Axelsson, Anna Olsson, Linda Myrin Westesson, Aletta Falk, Johan Szamosi, Karin Sennfält
Real-world prophylactic usage of recombinant factor VIII Fc in Sweden: A report from the Swedish national registry for bleeding disorders. Haemophilia : the official journal of the World Federation of Hemophilia 27 (4) (2021)
Alexandros Arvanitakis, Erik Berntorp, Jan Astermark
A comparison of MyPKFiT and WAPPS-Hemo as dosing tools for optimizing prophylaxis in patients with severe haemophilia A treated with Octocog alfa. Haemophilia : the official journal of the World Federation of Hemophilia 27 (3) (2021)
Kristina Kihlberg, Fariba Baghaei, Maria Bruzelius, Eva Funding, Pål Andre Holme, Riitta Lassila, Vuokko Nummi, Susanna Ranta, Mehdi Osooli, Erik Berntorp, Jan Astermark
Treatment outcomes in persons with severe haemophilia B in the Nordic region: The B-NORD study. Haemophilia : the official journal of the World Federation of Hemophilia 27 (3) (2021)
Eric Manderstedt, Christina Lind-Halldén, Rolf C R Ljung, Jan Astermark, Christer Halldén
Identification of F8 rearrangements in carrier and non-carrier mothers of haemophilia A patients. Haemophilia : the official journal of the World Federation of Hemophilia 27 (5) (2021)
Katharina Holstein, Sandra Le Quellec, Robert Klamroth, Angelika Bátorová, Pål Andre Holme, Victor Jimenez Yuste, Jan Astermark
Immune tolerance induction in the era of emicizumab - still the first choice for patients with haemophilia A and inhibitors? Haemophilia : the official journal of the World Federation of Hemophilia 28 (2) (2021)
Jan Astermark, Cedric Hermans, Monia Ezzalfani, Samuel Aballéa, Elena Santagostino, Zalmai Hakimi, Jameel Nazir
rFIXFc prophylaxis improves pain and levels of physical activity in haemophilia B: Post hoc analysis of B-LONG using haemophilia-specific quality of life questionnaires. Haemophilia : the official journal of the World Federation of Hemophilia (2021)
Cecilia Augustsson, Eva Norström, Vivian Lind, Myriam Martin, Jan Astermark, Karin Strandberg
Validation of factor VIII activity for monitoring standard and extended half-life products and correlation to thrombin generation assays. Haemophilia : the official journal of the World Federation of Hemophilia 27 (3) (2021)
Jan Astermark, Anna Olsson, Pierre Chelle, Kinga Täckström, Maria Walger, Maria Magnusson, Alfonso Iorio
Comparison of single subject and population-based pharmacokinetics for optimizing prophylaxis with simoctocog alfa in patients with haemophilia A. Haemophilia : the official journal of the World Federation of Hemophilia 27 (4) (2021)
Amy D Shapiro, Margaret V Ragni, Munira Borhany, Yasmina L Abajas, Michael D Tarantino, Katharina Holstein, Stacy E Croteau, Riana Liesner, Cristina Tarango, Manuela Carvalho, Catherine E McGuinn, Eva Funding, Christine L Kempton, Christoph Bidlingmaier, Alice Cohen, Johannes Oldenburg, Susan Kearney, Christine Knoll, Philip Kuriakose, Suchitra Acharya, Ulrike M Reiss, Roshni Daniel Kulkarni, Michelle L Witkop, Stefan Lethagen, Sharyne Donfield, Petra LeBeau, Erik Berntorp, Jan Astermark
Natural history study of factor IX deficiency with focus on treatment and complications (B-Natural). Haemophilia : the official journal of the World Federation of Hemophilia 27 (1) (2020)
Ragnhild J Måseide, Erik Berntorp, Jan Astermark, Anna Olsson, Maria Bruzelius, Tony Frisk, Vuokko Nummi, Riitta Lassila, Geir E Tjønnfjord, Pål A Holme
Joint health and treatment modalities in Nordic patients with moderate haemophilia A and B - The MoHem study. Haemophilia : the official journal of the World Federation of Hemophilia 26 (5) (2020)
Mehdi Osooli, Sharyne M Donfield, Katarina Steen Carlsson, Fariba Baghaei, Margareta Holmström, Erik Berntorp, Jan Astermark
Joint comorbidities among Swedish carriers of haemophilia: A register-based cohort study over 22 years. Haemophilia : the official journal of the World Federation of Hemophilia 25 (5) (2019)
Olav Versloot, Erik Berntorp, Pia Petrini, Rolf Ljung, Jan Astermark, Margareta Holmström, Piet de Kleijn, Kathelijn Fischer
Sports participation and physical activity in adult Dutch and Swedish patients with severe haemophilia: A comparison between intermediate- and high-dose prophylaxis. Haemophilia : the official journal of the World Federation of Hemophilia 25 (2) (2019)